(Q43690554)

25 November 2017

title

Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitro (English)

1 reference

encephalopathy due to GLUT1 deficiency

25 November 2017

0 references

1 reference

Ho YY

1

1 reference

25 November 2017

Yang H

2

1 reference

25 November 2017

Klepper J

3

1 reference

25 November 2017

Fischbarg J

4

1 reference

25 November 2017

Wang D

5

1 reference

25 November 2017

De Vivo DC

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

50

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

254-260

1 reference

Mammalian passive glucose transporters: members of an ubiquitous family of active and passive transport proteins

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

The glucose transporter family: structure, function and tissue-specific expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

Defective Glucose Transport across the Blood-Brain Barrier as a Cause of Persistent Hypoglycorrhachia, Seizures, and Developmental Delay

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

Defective glucose transport across brain tissue barriers: a newly recognized neurological syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

Methylxanthines inhibit glucose transport in rat adipocytes by two independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

Caffeine as a potential risk factor for theophylline neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

Pro-convulsant actions of theophylline and caffeine in the hippocampus: implications for the management of temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

Epileptogenic actions of xanthines in relation to their affinities for adenosine A1 receptors in CA3 neurons of hippocampal slices (guinea pig).

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

Caffeine-mediated induction of c-fos, zif-268 and arc expression through A1 receptors in the striatum: different interactions with the dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

Deficient transport of dehydroascorbic acid in the glucose transporter protein syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

Positron emission tomography study of human brain functional development

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

Glucose transporter proteins in brain: delivery of glucose to neurons and glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200108000-00015

10.1203/00006450-200108000-00015

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

25 November 2017

1002323101

0 references

1 reference